Generic name: dolutegravir
Brand names: Tivicay
Class: Individual integrase inhibitors (INSTIs)
Common: Nausea, diarrhoea, headache, rash, itching, vomiting, stomach pain or discomfort, insomnia (difficulty sleeping), dizziness, abnormal dreams, fatigue, flatulence, depression, increase in liver enzymes, increase in creatine phosphokinase (enzymes produced in the muscles).Rare: Allergic reaction, liver inflammation, suicidal thoughts and behaviours.
One 50mg tablet, once a day.For HIV known to be resistant to integrase inhibitors, or if you are taking dolutegravir with certain other medicines, the dose is 50mg twice a day with food.
Can be taken with or without food.
If you are taking dolutegravir twice a day, you may be advised to take it with food.
*Last review: 25/09/2015 Next review: 25/09/2018
Any questions? Email firstname.lastname@example.org Information included on this website was correct at the time of publication.
Data and image supplied by NAM.
Various people talk about their experiences of living with HIV.
CAB - Citizens Advice Bureau
HIV Drug Interactions
George House Trust
Equality and Human Rights Commission
Copyright 2018 © Terrence Higgins Trust is a registered charity in England and Wales (reg. no. 288527)
Company reg. no. 1778149 and a registered charity in Scotland (reg. no. SC039986). Registered office: 314-320 Gray's Inn Road, London, WC1X 8DP.